Citigroup Inc Unity Biotechnology, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.56 - $1.29 $11,626 - $26,781	-20,761 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.72 - $1.86 $14,947 - $38,615	20,761 New	20,761 $23,000
Q4 2021 Feb 10, 2022	SELL	$1.3 - $3.17 $3,838 - $9,361	-2,953 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$2.91 - $4.5 $8,593 - $13,288	2,953 New	2,953 $9,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.